Team
health

TIMI Score for STEMI Calculator

The TIMI Score for STEMI (Thrombolysis In Myocardial Infarction for ST-segment Elevation Myocardial Infarction) stratifies acute myocardial infarction patients by mortality risk in the 30 days following admission. Cardiologists and emergency physicians use this bedside tool to guide post-infarction management intensity and prognostication. The score incorporates eight readily available clinical variables—age, comorbidities, vital signs, and physical examination findings—to generate a risk estimate that reflects real patient outcomes from large clinical trials.

Last updated:

Creators Łucja Zaborowska, MD, PhD
3,623 people find this calculator helpful

When to Use the TIMI STEMI Risk Score

Chest pain presenting to the emergency department demands rapid assessment and stratification. When electrocardiography confirms ST-segment elevation or left bundle branch block in the appropriate clinical context, myocardial infarction diagnosis is established and treatment is initiated urgently. However, not all STEMI patients carry identical prognosis. Even after successful reperfusion therapy (percutaneous coronary intervention or thrombolysis), significant variability in short-term mortality exists between individuals.

The TIMI STEMI score quantifies this risk using variables collected during initial evaluation and the first hours of hospital admission. Understanding individual mortality risk guides decisions about monitoring intensity, choice of adjunctive therapies, and family counselling. The score specifically predicts all-cause 30-day mortality—the critical period during which post-infarction complications and cardiogenic shock develop most frequently.

TIMI STEMI Risk Score Calculation

The TIMI score combines eight clinical parameters, each weighted by their adjusted odds ratios from the original validation cohort. The total points determine mortality risk stratification.

TIMI Score = Age + Comorbidities + Systolic BP + Heart Rate + Killip Class + Weight Category + Anterior ST Elevation/LBBB + Time to Treatment

  • Age — 2 points if 65–74 years; 3 points if ≥75 years; 0 points if <65 years
  • Diabetes, hypertension, or angina — 1 point if any present; these increase baseline CAD risk
  • Systolic blood pressure — 1 point if <100 mmHg; reflects haemodynamic compromise
  • Heart rate — 1 point if ≥100 bpm; indicates sympathetic activation and stress response
  • Killip class II–IV — 2 points if clinical signs of heart failure present; 0 points for Killip I
  • Weight category — 1 point if <67 kg; reflects smaller body size and reduced physiological reserve
  • Anterior ST elevation or LBBB — 1 point if anterior leads (I, aVL, V1–V4) show elevation or LBBB pattern
  • Time to treatment — 1 point if >3 hours from symptom onset; longer ischaemia time worsens myocardial damage

Understanding the Eight TIMI Criteria

Age serves as a foundational risk marker; patients aged 75 years or older receive maximum points. The presence of diabetes, prior hypertension, or previous angina identifies those with chronic vascular disease burden. Systolic blood pressure below 100 mmHg suggests cardiogenic shock development, which dramatically increases mortality. Elevated heart rate (≥100 bpm) reflects the body's compensatory response to reduced cardiac output.

The Killip classification—derived from bedside heart failure assessment—is the single strongest predictor in the score. Patients with pulmonary congestion, peripheral oedema, or cardiogenic shock (Killip II–IV) face substantially higher risk than those with no signs (Killip I). Body weight interacts with medication dosing and physiological tolerance. Anterior infarction location or concomitant left bundle branch block indicates larger myocardium affected. Finally, symptom-to-treatment time longer than three hours correlates with greater irreversible myocardial necrosis.

Killip Classification Deep Dive

The Killip system, established in 1967, remains the gold standard for bedside heart failure severity assessment in acute myocardial infarction. Its continued validation into the 21st century confirms that physical examination findings predict mortality independently of echocardiographic or biochemical markers.

  • Killip I: No clinical signs of heart failure; normal pulmonary and systemic venous pressures
  • Killip II: Mild heart failure; rales audible in lung bases or elevated jugular venous pressure
  • Killip III: Moderate to severe pulmonary oedema; crackles throughout lung fields
  • Killip IV: Cardiogenic shock; hypotension (systolic <90 mmHg), peripheral hypoperfusion, oliguria despite adequate filling pressures

Progression through Killip classes correlates directly with escalating mortality. Killip I patients enjoy approximately 5% 30-day mortality, whereas Killip IV carries risks exceeding 50% even with modern intensive care.

Clinical Application Tips

Accurate TIMI scoring depends on careful data collection and interpretation of individual components.

  1. Killip assessment requires deliberate physical examination — Do not rely solely on vital signs or imaging to classify heart failure severity. Perform auscultation, assess for peripheral oedema, measure jugular venous pressure, and evaluate perfusion. A patient with low blood pressure and peripheral coolness meets Killip IV criteria even without overt pulmonary congestion.
  2. Time to treatment window shapes prognostication — The score specifically penalises presentation >3 hours from symptom onset. This reflects myocardial salvage potential—earlier reperfusion preserves viable tissue. However, late presenters (24+ hours) with stable haemodynamics may have lower predicted risk than the raw score suggests, as irreversible damage is already demarcated.
  3. Blood pressure interpretation requires context — Hypotension in the context of STEMI is grave. However, baseline chronic hypertension and acute medications (nitrates, ACE inhibitors) complicate interpretation. Use admission blood pressure before aggressive pharmacotherapy when scoring.
  4. Age thresholds create score transitions — The jump from 0 to 2 points at age 65 and from 2 to 3 points at 75 reflects non-linear risk increase. A 64-year-old and a 65-year-old with identical other parameters score differently—be aware of this when counselling patients near thresholds.

Frequently Asked Questions

What does a TIMI score of 8 or higher mean for a STEMI patient?

A score of 8 or above places the patient in a high-risk category, with 30-day mortality risk typically exceeding 25–30%. This indicates the need for intensive monitoring, early consideration of mechanical circulatory support (intra-aortic balloon pump or extracorporeal membrane oxygenation) if cardiogenic shock develops, and possibly earlier invasive imaging to identify complications. High scores do not preclude aggressive treatment but do warrant heightened vigilance during the critical first 72 hours.

Why is Killip class weighted so heavily in the TIMI STEMI score?

Killip class captures the functional consequence of myocardial injury through clinical signs of heart failure. It integrates information about left ventricular function, pulmonary vascular pressures, and systemic perfusion into a single bedside assessment. Because heart failure severity directly reflects the extent and acuity of myocardial dysfunction, it is the strongest independent predictor of mortality—stronger than any single laboratory value or imaging finding alone.

Can the TIMI score be calculated before coronary angiography?

Yes. The TIMI STEMI score uses only variables available at hospital admission or shortly thereafter, before catheterisation. This makes it ideal for initial risk stratification in the emergency department, guiding triage decisions and family discussions while awaiting angiography. The score does not require knowledge of coronary anatomy or left ventricular ejection fraction.

How does the TIMI STEMI score differ from other myocardial infarction risk models?

The TIMI STEMI score is specifically designed for ST-elevation infarction and includes the Killip classification, which is particularly relevant for acute STEMI pathophysiology. Other models like GRACE or HEART scores are tailored for unstable angina or non-STEMI populations. TIMI STEMI focuses on 30-day all-cause mortality and performs best in the acute phase rather than for long-term prognostication.

Is the TIMI STEMI score applicable to patients receiving thrombolytic therapy rather than PCI?

Yes. The score was developed and validated across both reperfusion strategies. However, the time variable (>3 hours from symptom onset) assumes initiation of reperfusion therapy; outcomes differ substantially if no reperfusion is attempted. The score applies to any STEMI patient receiving standard-of-care treatment within the acute window.

What should be done if a TIMI score indicates very high risk?

High-risk patients warrant continuous cardiac monitoring, serial troponin and BNP measurement, and echocardiography to assess left ventricular function and exclude mechanical complications (ventricular septal rupture, papillary muscle rupture). Consider early advanced imaging (cardiac MRI or CT), consultation with cardiac surgery if mechanical complications are suspected, and discussion with the patient and family about realistic outcomes and goals of care.

More health calculators (see all)

Ovulation Calculator qSOFA Calculator Maddrey's Discriminant Function Calculator Benadryl Dosage Calculator Gabapentin Dosage Calculator Time of Death Calculator Mortality Rate Calculator Gout Diagnosis Calculator